Neus is a neurologist and researcher specialized in the diagnostic assessment of cognitive disorders and their clinical management. The overarching goal of her research is to improve the diagnostic framework of Alzheimer's disease.
Dr. Lea Grinberg, Dr. Raquel Sánchez-Valle
Words of Strength
To reduce the impact of dementia we need to take care of all the aspects directly affecting the patients' quality of life, as well as to develop accurate tools for an early diagnosis and tailored treatments.
Neus is working to better understand the underlying mechanisms of sleep-wake alterations in the early stages of Alzheimer's disease. This can help to promote novel diagnostic biomarkers and identify novel targets for drug development.
Her journey as an Atlantic Fellow has reinforced his commitment to improving Alzheimer's disease's diagnostic framework. The enriching and inspiring atmosphere at UCSF has widened his perspectives on Alzheimer's disease neurobiological basis to embrace novel sleep-related biomarkers in his research.
Sleep disturbances are underdiagnosed and mistreated in dementia patients, and they have a very negative impact on patients and their families. There is a need to improve diagnostic tools and promote tailored treatments to provide better care to our patients.
Neus Falgàs completed the neurology residency at the Hospital Clínic de Barcelona where she was awarded as the best training resident (2016, 2017). In 2016, she was granted by the hospital to complete her training as a behavioral neurologist (predoc fellowship) at the Alzheimer's Unit while developing a three-year research project. This project, which was awarded by the Spanish Society of Neurology (2016), allowed her to complete the Ph.D. thesis centered on the performance of diagnostic biomarkers in early-onset Alzheimer's disease (Universitat de Barcelona, 2019). After the inspiring experience as an Atlantic Fellow at GBHI-UCSF, Neus is currently working at UCSF into the research sleep-wake alterations and related biomarkers, in collaboration with the Alzheimer Unit (lead by Dr. Raquel Sánchez-Valle) and Sleep Unit (lead by Dr. Alex Iranzo) at Hospital Clínic.
Universitat de Barcelona
Usefulness of biochemical and neuroimaging biomarkers in early-onset Alzheimer’s disease diagnosis